coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Coastal And South Downs PCN, Arun · Health Inequalities Profile

    PCN U49536 · NHS Surrey and Sussex Integrated Care Board; NHS Sussex Integrated Care Board · 2 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    31,459

    Registered population

    52.7% aged 18–64

    31.8%

    Aged 65+

    ICB 21.9% · England 17.9%

    6.5%

    Ethnic minority (non-White)

    2.8% Asian · England 9.6%

    0.8%

    In IMD quintile 1

    ICB 9.2% · England 21.0%

    ~252

    Core20 residents (est.)

    Resident basis; registered basis ~260 · see page 3

    6,405

    Hypertension register

    +4.52% in 3 yrs · England +5.60%

    308

    SMI register

    15.4% of Arun's

    682

    COPD register

    Reviews +6.61% in 3 yrs

    Forecast to 2030

    7,242

    Hypertension patients, 2030

    +837 on today

    60.1%

    QRISK ≥20% on statins, 2030

    +1.11pp over 3 yrs

    4.8%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    57.9%
    Hypertension control and recent recording trail England.

    Hypertension control is 57.9% (England 70.3%, -3.2% over 2023 to 2025) and BP recording is 82.7% (England 90.0%), which may reflect review capacity.

    81.5%
    Smoking cessation offers and asthma recording lag.

    Smoking cessation offers are 81.5% (England 94.2%, -3.6 pp over 2023 to 2025) and youth asthma second-hand smoke recording is 65.5% (England 78.8%).

    87.8%
    SMI physical checks and breast screening lead.

    SMI blood pressure checks reach 87.8% (England 83.4%, +12.5 pp over 2023 to 2025), alongside 85.7% BMI recording and 82.3% breast screening (England 69.9%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Patients aged 65 and over comprise 31.8% of the list, well above England

    Across 31,459 registered patients, 31.8% (9,990) are aged 65+, compared to 29.2% in Arun, 21.9% in NHS Sussex Integrated Care Board, and 17.9% in England. Between practices, this ranges from 28.8% at Lime Tree Surgery to 52.8% at Barn Surgery. Census estimates for resident catchments show 93.5% White (Arun 95.8%, NHS Sussex Integrated Care Board 91.0%, England 81.1%) and a 6.5% ethnic minority share, including 2.8% Asian / Asian British residents (Arun 1.6%, NHS Sussex Integrated Care Board 3.7%, England 9.6%). These census figures describe local residents rather than registered patients.

    Age profile

    0–1715.6%
    18–6452.7%
    65+31.8%

    65+: ICB 21.9%, England 17.9%

    Ethnicity

    White93.5%
    Asian2.8%
    Mixed2.2%
    Black0.8%
    Other0.7%

    Older people · falls rows are Arun local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Arun LA)2,3272,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)78.9%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)58.9%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Arun LA)1,2169819552024/25
    Falls deaths, all ages, per 100,000 (Arun LA)13.314.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Deprivation is low overall with all estimated 260 Core20 patients at Lime Tree Surgery

    Average IMD decile is 7.4, compared with 5.6 in Arun, 6.1 in NHS Sussex Integrated Care Board, and 5.5 in England. Registered patients in Core20 areas stand at 0.8%, below Arun (9.8%), NHS Sussex Integrated Care Board (9.2%), and England (21.0%). Core20 volume is concentrated at Lime Tree Surgery with an estimated 260 patients (0.9% share), while Barn Surgery records 0.0%. Modelled practice figures differ from the 252 estimated Core20 residents. Core20 interventions require focused practice targeting rather than PCN-wide deployment.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Lime Tree0.9% · 260 patients
    Barn0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    308

    SMI register

    0.97% recorded prevalence

    229

    Learning disability register

    0.72% recorded prevalence

    27

    Care homes, 695 beds

    In the PCN catchment

    8.9%

    Provide unpaid care

    Arun, Census 2021

    Recorded registers include 308 patients on the severe mental illness register (1.0%, matching England 1.0%) and 229 with learning disabilities (0.7% vs England 0.6%). Catchment infrastructure includes 27 care homes with 695 beds, though this does not confirm registered resident numbers. With learning disability prevalence above England, annual health checks and care-home multidisciplinary reviews are the key inclusion workloads to sustain.

    Severe mental illness: physical health checks

    SMI checks exceed England for blood pressure (87.8% vs 83.4%) and BMI (85.7% vs 82.1%). Smoking cessation offers trail at 81.5% (England 94.2%), falling 3.6 pp over 2023 to 2025 (England +0.1 pp).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    6,405

    Hypertension register

    +4.52%

    Register growth, 3 yrs

    Arun +4.55% · England +5.60%

    +0.27pp

    BP control, under 80

    ≤140/90 · +2.06pp aged 80+

    +837

    More patients by 2030

    Forecast 7,242 (22.08%)

    Hypertension case-finding and control

    The PCN records hypertension prevalence of 20.2% (6,405 patients), above Arun (19.8%), NHS Sussex Integrated Care Board (16.3%) and England (15.2%). Blood pressure recording trails at 82.7% against Arun (89.4%), NHS Sussex Integrated Care Board (90.2%) and England (90.0%), falling 2.8% over 2023 to 2025 (England +3.6%). Patients treated to target reached 57.9% against Arun (68.8%), NHS Sussex Integrated Care Board (69.1%) and England (70.3%), falling 3.2% (England +3.6%). Recording is 84.8% at Lime Tree Surgery and 73.2% at Barn Surgery; control is 60.1% at Lime Tree Surgery and 48.6% at Barn Surgery. Hypertension monitoring and control trail England, so prioritizing structured recall and medication titration could improve control.

    Lipids and statins

    Among patients with QRISK ≥ 20%, lipid-lowering therapy reaches 57.8%, trailing Arun (62.5%), NHS Sussex Integrated Care Board (60.0%) and England (63.6%), with growth of +1.9% over 2023 to 2025 behind England (+6.2%). Lower uptake than comparators suggests scope to review clinical recall for at-risk patients.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202674,729£2.70£2.42£1.86£201,768
    Cardiovascular (all), 202598,778£3.03£3.32£3.33£299,297

    For lipid-regulating drugs in 2026, the PCN prescribed 74,729 items at £2.70 per item, below Arun (£2.81) but above NHS Sussex Integrated Care Board (£2.42) and England (£1.86), spending £62,772 more than at England's unit cost across 74,729 items. This unit-cost indicator does not establish inefficiency, though formulary review could explore cost drivers.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +13.09%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +1.53%

    Asthma prevalence, PCN 3-yr % change

    The PCN records 682 COPD patients (2.1% prevalence vs England 1.9%) and 2,279 asthma patients (7.5% vs England 6.6%). COPD 12-month reviews reach 69.3% (England 76.4%), with Lime Tree Surgery at 67.2% and Barn Surgery at 82.3%. Second-hand smoke status recording for asthma patients aged 6 to 19 is 65.5% (England 78.8%), while asthma management items prescribed per 1,000 population aged 5 to 19 is 1,933 (England 1,488). Review shortfalls and pediatric exposure recording gaps suggest scope for proactive respiratory follow-up.

    Cancer register and children's immunisation

    The cancer register records 1,440 patients (4.5% prevalence vs England 3.8%), with three-year growth of +2.6% over 2023 to 2025 behind England (+9.0%). In Q1 2025/26, MMR dose 1 at age five reached 98.2% (target 95.0%), but dose 2 was 91.1% (denominator 60), trailing dose 1 by 7.1 pp and falling below the 95.0% target by 3.9 pp. The cross-sectional dose gap highlights potential for targeted pre-school recall.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months98.1%

    England 91.0%

    6-in-1 complete primary course at 24 months97.4%

    England 92.2%

    MMR dose 1 at 24 months97.4%

    England 88.3%

    MMR dose 2 at age 591.1%

    England 82.8%

    4-in-1 pre-school booster at age 592.9%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    58.5%

    Sussex ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,360

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Sussex ICBEnglandNo usable stageStaged cancers
    Prostate56.6%53.2%19%1,668
    Breast86.1%85.4%23%1,400
    Bowel49.8%47.0%26%1,133
    Lung30.3%33.8%15%1,058
    Skin cancer95.3%87.8%17%698

    In NHS Sussex ICB, 58.5% of cancers with a known stage (4,799 of 8,209) were diagnosed at stage 1 or 2 in 2022, above England (55.3%) but 16.5 percentage points below the 75.0% ambition by 2028. Staging completeness was 64.3% (8,209 of 12,766). Reaching the ICB ambition requires about 1,360 extra early-stage diagnoses yearly. Locally, breast (82.3%) and cervical screening (70.8%) exceed England (69.9% and 66.8%), yet PCN cancer register growth was +2.6% over 2023 to 2025 (England +9.0%), spanning +0.3% at Lime Tree Surgery to +12.4% at Barn Surgery. Slower register expansion may indicate under-recording of diagnosed cases, warranting systematic reconciliation.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In Jul 2026, University Hospitals Sussex NHS Foundation Trust achieved 65.2% on the 62-day standard (414 of 635), trailing Royal Surrey NHS Foundation Trust (84.5%), Surrey and Sussex Healthcare NHS Trust (70.0%), NHS Surrey and Sussex Integrated Care Board (71.5%), England (71.2%), and the 85.0% standard. Its 28-day faster diagnosis performance was 74.0%, below England (79.3%) and the 75.0% standard. Across all diagnostic tests, 12.9% waited 6+ weeks, but colonoscopy reached 39.3% (England 30.8%). Acute pathway and endoscopy bottlenecks could delay diagnosis and treatment following primary care referral.

    Pathways within standard (%)SussexSurrey and Sussex HealthcareRoyal SurreySurrey and Sussex ICBEngland
    28-day faster diagnosis (75%)74.0177.7482.6279.2979.32
    31-day treatment (96%)76.7996.2096.4390.4592.50
    62-day referral to treatment (85%)65.2069.9784.4871.5171.16
    Diagnostic waits over 6 weeks (%)SussexSurrey and Sussex HealthcareRoyal SurreyEngland
    MRI5.6227.530.0021.40
    CT8.5718.490.159.92
    Echocardiography0.3943.781.5528.48
    Colonoscopy39.3515.110.0030.83
    Gastroscopy20.0221.060.0029.02
    All 15 DM01 tests12.9528.508.8223.14
    Community services activityWest Sussex residentsSurrey and Sussex ICB
    Care contacts78,050309,615
    Referrals16,01566,930
    Patients with a contact19,77085,660

    Community services (residents of West Sussex), Jun 2026 (provisional). In Jun 2026, provisional community services recorded 78,050 care contacts across 19,770 West Sussex residents, with 115,485 care activities and 16,015 referrals. Adults aged 65+ accounted for 72.7% of these contacts (56,740). Across NHS Surrey and Sussex Integrated Care Board, 85,660 patients had 309,615 community contacts. Heavy community utilisation among older residents underlines the need for joined-up post-diagnosis cancer and palliative support.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Phone contact ease varies widely between practices despite similar overall satisfaction

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Barn Surgery1290.078.1%70.1%75.2%
    Lime Tree Surgery1040.954.0%77.8%73.3%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNArunAssetPCNArun
    Care homes (catchment)27 (695 beds)n/aSchools (catchment)28n/a
    Children's centres47Places of worship2668
    Libraries47Homelessness support (VCS)0no data
    Day centres (VCS)n/a1Carers support groups (VCS)n/a1
    Primary schools (LA maintained)1021Primary academies519
    Special schools11

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured hypertension recall and titration

    Across 6,405 hypertensive patients (20.2% prevalence), control is 57.9% (12.4 pp below England's 70.3%, falling 3.2% vs England +3.6%) and recording is 82.7% (England 90.0%). For discussion: establish pharmacist-led recall and titration for uncontrolled hypertensive patients at Barn Surgery (48.6% control) and Lime Tree Surgery (60.1%). Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 2

    Smoking cessation offer template review

    Smoking cessation support offered is 81.5% (denominator includes PCAs), 12.7 pp below England (94.2%) and 13.2 pp below Arun (94.7%), falling 3.6 pp (England +0.1 pp). For discussion: standardise review templates and prompts across both practices so smoking cessation offers and pediatric second-hand smoke checks are consistently recorded. Low cost, quick to run.

    Option 3

    High-risk lipid therapy and formulary review

    QRISK ≥ 20% lipid therapy is 57.8% (5.8 pp below England's 63.6%, growing +1.9% vs England +6.2%); 2026 lipid-modifying prescribing spent £62,772 more than at England's unit cost across 74,729 items. Moderate effort to run.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Proactive frailty review planning (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Targeted Core20 practice outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Smoking cessation protocol review (p4)Smoking cessation support and treatment offered to patients with certain conditions (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Hypertension recall and titration (p5)Hypertension patients treated to targetCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school MMR recall audit (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cancer register coding reconciliation (p7)Cancer: QOF prevalenceCore20PLUS5, 75% stage 1–2 by 2028PCN
    Telephone access review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Structured hypertension recall and titration (p12)Hypertension register · Hypertension: QOF prevalence · Hypertension patients with a recent BP readingCore20PLUS5 CVD · CVDPREVENT 2029PCN & Practice
    Option 2 · Smoking cessation offer template review (p12)Smoking cessation support and treatment offered to patients with certain conditions (denominator incl. PCAs) · Patients with Asthma (6-19 yrs): Second-hand smoking status recorded in the last 12 months (denominator incl. PCAs)—PCN
    Option 3 · High-risk lipid therapy and formulary review (p12)Patients with QRISK ≥ 20% treated with lipid lowering therapy · CKD patients treated with lipid lowering therapy · Count of Items prescribed for Lipid-regulating drugs 2026—PCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15